A study has revealed why some patients don't respond to immune checkpoint blockade (ICB) therapy for solid cancer tumors and ...

We know from the phase 2 TROPHY-U-01 trial that sacituzumab govitecan is an active drug, with an objective response rate of ...

The FDA has granted Fast Track designation to TEV-53408, an investigational anti-interleukin-15 antibody, for the treatment of celiac disease.

Research from KFRI uncovers competitive dynamics among A. muciniphila subtypes, highlighting their role in gut health and ...

The US government has canceled a $600 million contract with Moderna to develop a vaccine for bird flu and other dangerous flu strains, raising concerns among experts.

This five-year analysis of the C-144-01 trial represents unprecedented durability and duration of follow-up in advanced melanoma patients previously treated with anti-PD-1 and targeted therapy, where ...

June 2, 2025 - Last Friday, the World Health Organization (WHO) published its first-ever position paper on immunization ...

The EPA had a golden opportunity to clean up its act on “forever chemicals”—and fumbled spectacularly. Instead of addressing ...

ISB 2001, a first-in-class trispecific antibody developed by IGI, showed a 79% response rate in relapsed/refractory multiple ...

For Poolbeg Pharma, the question is not simply whether it can fund its ambitions, but whether its pipeline can justify them.

Vitamin B12, or cobalamin, is crucial for energy production, nerve health, and a robust immune system. It boosts white blood ...

Researchers at The University of Warwick have published the first example of a synthetic sugar detection test for snake venom, offering a new route to rapid diagnosis and better antivenoms.